sb.scorecardresearch
Advertisement

Published 11:34 IST, July 11th 2020

Gilead Sciences says remdesivir reduces risk of death in COVID-19 patients

Gilead's Remdesivir was associated with an improvement in clinical recovery and a 62 percent reduction in the risk of mortality compared with standard of care.

Reported by: Zaini Majeed
Follow: Google News Icon
  • share
Gilead
null | Image: self
Advertisement

Loading...

11:34 IST, July 11th 2020